ASCO® GU 2024 Insights: "Subcutaneous vs. Intravenous Nivo for Previously Treated Advanced or Metastatic ccRCC: Pharmacokinetics, Efficacy, and Safety Results From CheckMate 67T"
By
Insights from 2024 ASCO® GU Annual Meeting
FEATURING
Saby George
By
Insights from 2024 ASCO® GU Annual Meeting
FEATURING
Saby George
Comments 0
Login to view comments.
Click here to Login
